1.Current Situation of Medical Student Abuse
Shizuko NAGATA-KOBAYASHI ; Miho SEKIMOTO ; Hiroshi KOYAMA ; Wari YAMAMOTO ; Eiji GOTO ; Osamu FUKUSHIMA ; Teruo INO ; Atsushi ASAI ; Shunzo KOIZUMI ; Tsuguya FUKUI ; Takuro SHIMBO
Medical Education 2007;38(1):29-35
1) To our knowledge, medical student abuse has not previously been studied in Japan.
2) In our survey, 68.5% of respondents experienced medical student abuse.
3) Several students reported that they had been frequently neglected or ignored by teaching physicians during clinical clerkships and that such attitudes discouraged them and decreased their motivation.
4) To improve the learning environment, medical educators must take action to resolve this serious issue.
2.Successful introduction of modified dorsolumbar epidural anesthesia in a bovine referral center.
Miho HIRAOKA ; Toshiharu MIYAGAWA ; Hayato KOBAYASHI ; Toshihiko TAKAHASHI ; Hiroaki KISHI ; Hiroshi KOBAYASHI ; Inhyung LEE
Journal of Veterinary Science 2007;8(2):181-184
This study describes the successful use of modified dorsolumbar epidural anesthesia with a fixed volume of anesthetic in a bovine referral center. Among the 130 Holstein cattle scheduled for flank surgery, 90 cattle received a mixed anesthetic consisting of 1 ml of xylazine hydrochloride and 3 ml of lidocaine hydrochloride by modified dorsolumbar epidural anesthesia. Eighteen cattle with dehydration and/or lameness received a mixed anesthetic containing 0.5 ml of xylazine and 3 ml of lidocaine. Infiltration anesthesia was performed in 22 cattle whose epidural space could not be reached in order to perform the flank surgery. The surgeries began about 12 min after the administration of the anesthetic and lasted for about 36 min. The modified method using a fixed volume of anesthetic was successfully introduced and effectively used in a bovine referral center. This modified method will allow veterinarians to save time and effort, thus lowering the cost of each surgery.
Anesthesia, Epidural/methods/*veterinary
;
Anesthetics, Local/*administration & dosage
;
Animals
;
Cattle/*surgery
;
Epidural Space
;
Female
;
Lidocaine/*administration & dosage
;
Lumbar Vertebrae
;
Xylazine/*administration & dosage
3.Effects of Anti-Oketsu Drugs, Keishibukuryogan and Tokishakuyakusan on Platelet Aggregation in Normal Human Volunteer
Shizuko TAKANO ; Kozue SUZUKI ; Akiko FUJISAKI ; Miho FUTAGAMI ; Fumihito ITO ; Yuko ONO ; Shinichi SAI ; Makiho KATAKURA ; Tomoko OISHI ; Kenta SUGAYA ; Seiichi ISHIBASHI ; Yuuko KOBAYASHI ; Michiko ABE ; Yuhko DAIGAKU ; Satomi MIYAMOTO
Kampo Medicine 2005;56(4):561-566
Effects of anti-oketsu drug, Keishibukuryogan (Gui-zhi-fu-ling-wan) and Tokishakuyakusan (Dang-gui-shao-yao-san) in vivo and in vitro on platelet aggregation were investigated in normal volunteers.
Of 20 volunteers who were given Keishibukuryogan, there were 6, 3 and 11 subjects whose dose-response curves of collagen-induced aggregations were shifted to the right, to the left, or who had no shift, respectively. The control aggregations of these 20 people were in the same range. In ADP-induced aggregation, there were 5 curves shifted to the right. Their potencies in the control aggregation were higher than those of 9 subjects who were not affected by the drug. There were 6 curves shifted to the left, and their potencies were lower than those of the 9 unaffected subjects. Of 12 volunteers who were given Tokishakuyakusan, there were 2, 2 and 8 subjects whose dose-response curves in collagen-induced aggregation were shifted to the right, the left, or who had no shift respectively. With ADP-induced aggregation, there were 1, 1 and 10 subjects whose doseresponse curves were shifted likewise. In vitro, Keishibukuryogan caused inhibition of ADP-induced aggregation but not that of collagen-induced aggregation.
4.Changes in Registration Status of Identification Codes on PMDA’s Information Search Site of Pharmaceuticals for Prescription
Yasushi HABU ; Miho UENISHI ; Risa OSHIMBE ; Manabu TANIMURA ; Kayo TSUJII ; Masahiko KOBAYASHI
Japanese Journal of Drug Informatics 2023;25(2):98-106
The identification code of a drug is defined as “a code for identifying tablets, etc.” and is described in the “Composition/Properties” section of the package insert. We investigated whether the Pharmaceuticals and Medical Devices Agency (PMDA) website, which allows users to search package insert information, can be used for drug identification using identification codes in 2019 before the new package insert guidelines were implemented, and in 2022, during the revision period. Approximately 30% of the investigated high-risk drugs were unidentifiable in both years. The most common reason was that images were used to register identification codes on the PMDA website, and character strings were not searchable. We then conducted a questionnaire survey of pharmaceutical companies, and only approximately half of the respondents opined that it would be preferable if the registration format for identification codes was established within the pharmaceutical industry. However, hospital pharmacists urged for more simplified identification of drugs on the PMDA website.
5.TP53 variants in p53 signatures and the clonality of STICs in RRSO samples
Tomoko AKAHANE ; Kenta MASUDA ; Akira HIRASAWA ; Yusuke KOBAYASHI ; Arisa UEKI ; Miho KAWAIDA ; Kumiko MISU ; Kohei NAKAMURA ; Shimpei NAGAI ; Tatsuyuki CHIYODA ; Wataru YAMAGAMI ; Shigenori HAYASHI ; Fumio KATAOKA ; Kouji BANNO ; Kokichi SUGANO ; Hajime OKITA ; Kenjiro KOSAKI ; Hiroshi NISHIHARA ; Daisuke AOKI
Journal of Gynecologic Oncology 2022;33(4):e50-
Objective:
Precursor lesions may be identified in fallopian tube tissue after risk-reducing salpingo-oophorectomy (RRSO) in patients with pathogenic variants of BRCA1/2. Serous tubal intraepithelial carcinoma (STIC) is considered a precursor of high-grade serous carcinoma, whereas the significance of the p53 signature remains unclear. In this study, we investigated the relationship between the p53 signature and the risk of ovarian cancer.
Methods:
We analyzed the clinicopathological findings and conducted DNA sequencing for TP53 variants of p53 signatures and STIC lesions isolated using laser capture microdissection in 13 patients with pathogenic variants of BRCA1/2 who underwent RRSO and 17 control patients with the benign gynecologic disease.
Results:
TP53 pathogenic variants were detected significantly higher in RRSO group than control (p<0.001). No difference in the frequency of p53 signatures were observed between groups (53.8% vs 29.4%; p=0.17). TP53 sequencing and next-generation sequencing analysis in a patient with STIC and occult cancer revealed 2 TP53 mutations causing different p53 staining for STICs and another TP53 mutation shared between STIC and occult cancer.
Conclusion
The sequence analysis for TP53 revealed 2 types of p53 signatures, one with a risk of progression to STIC and ovarian cancer with pathological variants in TP53 and the other with a low risk of progression without pathological variants in TP53 as seen in control.
6.Serial Changes in Score on the Japanese Version of the Trail Making Test (TMT-J) After Minor Ischemic Stroke
Miho YOSHIOKA ; Zen KOBAYASHI ; Kaori KATO ; Keisuke INOUE ; Masaki HAKOMORI ; Kazunori TOYODA ; Yoshiyuki NUMASAWA ; Toshiya MATSUDA ; Yuki KATAYAMA ; Shoichiro ISHIHARA ; Hiroyuki TOMIMITSU ; Shuzo SHINTANI
Journal of the Japanese Association of Rural Medicine 2020;69(4):351-
The Trail Making Test (TMT) is a widely used measure of attention impairment. The time needed to complete the TMT (TMT score) is longer with greater impairment of attention in patients with brain diseases. TMT score becomes large in a proportion of patients with minor ischemic stroke. The Japanese version of the TMT- (TMT-J) was published in 2019. The purpose of this study was to clarify serial changes in TMT-J scores in patients with minor ischemic stroke. We retrospectively reviewed the TMT-J scores in those patients who completed the test both 8-14 days and 29-35 days after stroke onset. On initial evaluation, 1 of 21 patients could not complete TMT-J Part A. TMT-J Part A scores had a mean of 67 s and were abnormally large in 45% of the 20 patients who completed this part. Two of these 20 patients could not complete TMT-J Part B. TMT-J Part B scores had a mean of 135 s and were abnormally large in 61% of the 18 patients who completed this part. On second evaluation, scores on Part A and Part B improved in 76% and 73% of patients, respectively. This study demonstrated that abnormal TMT-J scores 8-14 days after onset of minor ischemic stroke improved over time in most patients.
7.Enhanced event-based surveillance for imported diseases during the Tokyo 2020 Olympic and Paralympic Games
Ayu Kasamatsu ; Masayuki Ota ; Tomoe Shimada ; Munehisa Fukusumi ; Takuya Yamagishi ; Anita Samuel ; Manami Nakashita ; Tomohiko Ukai ; Katsuki Kurosawa ; Miho Urakawa ; Kensuke Takahashi ; Keiko Tsukada ; Akane Futami ; Hideya Inoue ; Shun Omori ; Miho Kobayashi ; Takahisa Shimada ; Sakiko Tabata ; Yuichiro Yahata ; Hajime Kamiya ; Fumi Yoshimatsu ; Tomimasa Sunagawa ; Tomoya Saito
Western Pacific Surveillance and Response 2021;12(4):13-19
In 2021, the National Institute of Infectious Diseases, Japan, undertook enhanced event-based surveillance (EBS) for infectious diseases occurring overseas that have potential for importation (excluding coronavirus disease 2019 [COVID-19]) for the Tokyo 2020 Olympic and Paralympic Summer Games (the Games). The pre-existing EBS system was enhanced using the World Health Organization Epidemic Intelligence from Open Sources system and the BlueDot Epidemic Intelligence platform. The enhanced EBS before and during the Games did not detect any major public health event that would warrant action for the Games. However, information from multiple sources helped us identify events, characterize risk and improve confidence in risk assessment. The collaboration also reduced the surveillance workload of the host country, while ensuring the quality of surveillance, even during the COVID-19 pandemic.
8.Use of Epidemic Intelligence from Open Sources for global event-based surveillance of infectious diseases for the Tokyo 2020 Olympic and Paralympic Games
Manami Yanagawa ; John Carlo Lorenzo ; Munehisa Fukusumi ; Tomoe Shimada ; Ayu Kasamatsu ; Masayuki Ota ; Manami Nakashita ; Miho Kobayashi ; Takuya Yamagishi ; Anita Samuel ; Tomohiko Ukai ; Katsuki Kurosawa ; Miho Urakawa ; Kensuke Takahashi ; Keiko Tsukada ; Akane Futami ; Hideya Inoue ; Shun Omori ; Hiroko Komiya ; Takahisa Shimada ; Sakiko Tabata ; Yuichiro Yahata ; Hajime Kamiya ; Tomimasa Sunagawa ; Tomoya Saito ; Viema Biaukula ; Tatiana Metcalf ; Dina Saulo ; Tamano Matsui ; Babatunde Olowokure
Western Pacific Surveillance and Response 2022;13(3):18-24
The establishment of enhanced surveillance systems for mass gatherings to detect infectious diseases that may be imported during an event is recommended. The World Health Organization Regional Office for the Western Pacific contributed to enhanced event-based surveillance for the Tokyo 2020 Olympic and Paralympic Games (the Games) by using Epidemic Intelligence from Open Sources (EIOS) to detect potential imported diseases and report them to the National Institute of Infectious Diseases (NIID), Japan. Daily screening of media articles on global infectious diseases was conducted using EIOS, which were systematically assessed to determine the likelihood of disease importation, spread and significant impact to Japan during the Games. Over 81 days of surveillance, 103 830 articles were screened by EIOS, of which 5441 (5.2%) met the selection criteria for initial assessment, with 587 (0.6%) assessed as signals and reported to NIID. None of the signals were considered to pose a significant risk to the Games based on three risk assessment criteria. While EIOS successfully captured media articles on infectious diseases with a likelihood of importation to and spread in Japan, a significant manual effort was required to assess the articles for duplicates and against the risk assessment criteria. Continued improvement of artificial intelligence is recommended to reduce this effort.